2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

The START Study: A Phase 4 Study on the Real-World Utilization of Deutetrabenazine Initiated by a 4-Week Patient Titration Kit

K. Anderson, M. Konings, S. Finkbeiner, A. Cutler (Washington, USA)
The STEPWISE Parkinson study: a Smartphone Based Exercise Solution for Patients With Parkinson’s Disease

S. Schootemeijer, N. de Vries, E. Macklin, A. Ascherio, M. Schwarzschild, B. Bloem (Nijmegen, Netherlands)
The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker

S. Bhattacharjee, E. Vichayanrat, L. Watson, V. Iodice (London, United Kingdom)
The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease

G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, A. Baitimerov, O. Kachemaeva, R. Galimova, R. Magzhanov (Ufa, Russian Federation)
The Unmet needs for advanced Parkinson Disease in -Patients’ during the Covid-19 pandemic in Israel

N. Simantov, A. Socher, T. Gurevich (Tel-Aviv, Israel)
The use of artificial intelligence-based chatbot in Parkinson’s disease

G. Oyama, M. Ogawa, K. Morito, M. Kobayashi, Y. Yamada, K. Shinkawa, H. Kamo, T. Hatano, N. Hattori (Tokyo, Japan)
The USP Project: Understanding the Scope and Value of Parkinson’s Specialist Nursing

A. Hand, K. Mcewan, A. Clarke, S. Dalkin, A. Bate, R. Bradford, C. Allen, K. Mcdonald, S. Mccarthy, K. Brittain (Newcastle-upon-Tyne, United Kingdom)
The Vall d’Hebron Initiative for Parkinson (VHIP) cohort: a prospective, longitudinal and observational study enrolling de novo Parkinson’s disease (PD) patients and carriers of PD-linked mutations for biomarker and pathophysiology studies

D. Samaniego-Toro, L. Domingo-Rodriguez, M. Camprodon-Gómez, M. Armengol-Bellapart, V. González, S. Lucas-Del-Pozo, E. Xicoy, J. Riera-Heredia, D. Montpeyó, M. Martinez-Vicente, A. Laguna, J. Hernandez-Vara (Barcelona, Spain)
Therapeutic approach to botulinum injections for hemifacial spasm, post facial paralysis synkinesis and blepharospasm

G. Yahalom, A. Janah, R. Eichel (Jerusalem, Israel)
Therapeutic potential of luteolin in manganese induced Parkinson’s disease: Targeting neuroinflammation and oxidative stress.

S. Chib (Moga, India)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z